Annual Drug Patent Expirations for VIEKIRA+XR
Viekira Xr is a drug marketed by Abbvie Inc and is included in one NDA. There are twenty-one patents protecting this drug.
Drug patent litigation for VIEKIRA XR.
This drug has five hundred and twenty-seven patent family members in fifty-three countries.
The generic ingredient in VIEKIRA XR is dasabuvir sodium; ombitasvir; paritaprevir; ritonavir. Additional details are available on the dasabuvir sodium; ombitasvir; paritaprevir; ritonavir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com